Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome

SIMPLE SUMMARY: For decades, countless efforts have been devoted to developing targeted drugs to improve the prognosis of triple-negative breast cancer (TNBC). Among the novel therapies that have been approved for the clinical management of TNBC, immunotherapy shows great potential. Although excitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liying, Zhang, Fan, Liu, Zhenyu, Fan, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818757/
https://www.ncbi.nlm.nih.gov/pubmed/36612317
http://dx.doi.org/10.3390/cancers15010321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818757/
https://www.ncbi.nlm.nih.gov/pubmed/36612317
http://dx.doi.org/10.3390/cancers15010321

Ejemplares similares